5.4 Biomarker-guided treatment In the precision treatment strategy for gemcitabine resistance, biomarker guided treatment based on dynamic monitoring of RRM2 copy number based on ctDNA and multi-omics prediction models (such as the EXPLOR trial) provides a new paradigm for individualized intervention: Gemcitabine resistance, RRM2 gene copy number amplification drives resistance by accelerating deoxyribonucleotide triphosphate (dNTP) synthesis and enhancing DNA repair, while ctDNA-based liquid biopsy technology (such as ddPCR/NGS) can dynamically monitor the level of RRM2 amplification and track the evolution of resistant clones in real time
Its use has been attributed to the rise in autism
Some people may notice improvements in skin brightness and overall wellness within a few weeks, while others may require several sessions over a longer period
Hypertension controlling drugs, antacids, antibiotics, female hormones, anti-inflammatories, diuretics, anti-virals, antihistamines, cholesterol lowering, antidepressants and chemotherapy are such medications 5
